Mayne Pharma Group Limited (MYX.AX)

Compare

7.21

-0.02

(-0.28%)

At close: April 4 at 4:10:37 PM GMT+11

Mayne Pharma Group Ltd (MAYNF) (H1 2025) Earnings Call Highlights: Strong Growth in Women's ...

Despite challenges, Mayne Pharma Group Ltd (MAYNF) reports a 13% revenue increase and significant profitability improvements, driven by robust performance in the women's health segment.

GuruFocus.com last month

MYX.AX
-0.28%
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology

BRIDGEWATER, N.J., February 20, 2025--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total consideration of approximately USD $430 Million. The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recom

Business Wire last month

HLNE

MAYNF
Discover ASX Penny Stocks Featuring Mayne Pharma Group And Two Others

The Australian market recently witnessed the ASX200 reach an all-time intra-day high, reflecting a dynamic period for investors amid predictions of potential interest rate cuts by the Reserve Bank of Australia. In such a climate, identifying stocks with strong fundamentals becomes crucial, especially when considering penny stocks. Though often seen as relics of past market eras, penny stocks continue to offer compelling opportunities for growth and value in smaller or newer companies.

Simply Wall St. 2 months ago

RVT.AX

MAYNF

WAR.AX
Discover 3 ASX Penny Stocks With Market Caps Over A$100M

As the Australian stock market wraps up a year marked by an 8.8% rise, traders are taking a cautious approach on the final trading day of 2024, with ASX 200 futures indicating a slight dip. Despite this end-of-year volatility, investors continue to explore opportunities beyond established names, turning their attention to penny stocks—companies that may be smaller or newer but still hold significant potential. While the term "penny stocks" might seem outdated, these investments can offer...

Simply Wall St. 3 months ago

MAYNF

SVMLF

IVCTF
Discover Alto Metals And 2 More Exciting Penny Stocks On The ASX

The Australian market is poised for a modest rise, buoyed by positive developments on Wall Street and reports of a potential Middle East ceasefire. Amidst these broader market movements, investors often look to smaller or newer companies for unique opportunities. Penny stocks, despite their somewhat outdated name, can still offer significant value when backed by strong financials. In this article, we explore three such penny stocks on the ASX that combine balance sheet strength with the...

Simply Wall St. 4 months ago

AME.AX

MAYNF

XRF.AX
FEDERAL CONTRACEPTION PROPOSAL TO EXPAND ACCESS AND AFFORDABLE COVERAGE PAVES A STRONGER PATH FOR MAYNE PHARMA'S GROWTH IN WOMEN'S HEALTH

Mayne Pharma Group Limited (Mayne Pharma or the Company) (ASX: MYX), welcomes the Biden-Harris Administration's newly proposed rule to expand coverage of affordable contraception under the Affordable Care Act (ACA). The proposal aims to significantly increase coverage of contraception for the 52 million US women of reproductive age with private health insurance, making essential contraceptive care more accessible to women across the country.

PR Newswire 4 months ago

MAYNF
Discover 3 ASX Penny Stocks With Market Caps Over A$200M

The Australian market has seen a downturn, with the ASX200 dropping 1.3% to 8,235 points amid widespread sector retreats and adjusted expectations for RBA rate cuts. In such fluctuating conditions, investors often look beyond the major indices to explore opportunities in smaller or newer companies. Penny stocks, despite their somewhat outdated moniker, continue to offer intriguing possibilities for growth at lower price points by combining strong balance sheets with solid fundamentals.

Simply Wall St. 5 months ago

GRX.AX

WBTNF

MAYNF
Several Insiders Invested In Mayne Pharma Group Flagging Positive News

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

Simply Wall St. 5 months ago

MAYNF
Shareholders in Mayne Pharma Group (ASX:MYX) are in the red if they invested five years ago

Mayne Pharma Group Limited ( ASX:MYX ) shareholders should be happy to see the share price up 22% in the last month...

Simply Wall St. 6 months ago

MAYNF
Mayne Pharma Group Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Mayne Pharma Group ( ASX:MYX ) Full Year 2024 Results Key Financial Results Revenue: AU$388.4m (up 112% from FY 2023...

Simply Wall St. 7 months ago

MAYNF
Australia's Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement

In the lawsuit filed at the United States District Court for New Jersey, Mayne Pharma accused its rival of violating all 20 Orange Book-listed patents linked to IMVEXXY - a vaginal insert aimed at reducing pain during sexual intercourse after menopause. Orange Book-listed patents are those approved by the U.S. Food and Drug Administration (FDA) and deemed safe to use. The Australian drugmaker said it filed the lawsuit after a notification indicated Sun Pharma's submission of an Abbreviated New Drug Application (ANDA) to the FDA seeking approval to market a generic version of IMVEXXY.

Reuters 8 months ago

MYX.AX
-0.28%
ASX Growth Companies With Insider Ownership As High As 35%

The Australian stock market has shown positive momentum, rising 1.5% in the past week and achieving a 7.3% increase over the last year, with earnings expected to grow by 13% annually. In this buoyant environment, growth companies with high insider ownership can be particularly compelling, as they often signal strong confidence from those closest to the business.

Simply Wall St. 10 months ago

IPX

TAOFF

GDG.AX
Mayne Pharma Group Limited's (ASX:MYX) largest shareholders are individual investors with 38% ownership, institutions own 33%

Key Insights Significant control over Mayne Pharma Group by individual investors implies that the general public has...

Simply Wall St. 10 months ago

MAYNF
Favourable Signals For Mayne Pharma Group: Numerous Insiders Acquired Stock

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Simply Wall St. 11 months ago

MAYNF

Performance Overview

Return	MYX.AX	S&P/ASX 200 [XJO] (^AXJO)
YTD	+45.07%	-6.02%
1-Year	-0.28%	-1.36%
3-Year	+67.38%	+2.05%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Mayne Pharma Group Limited (MYX.AX)

Mayne Pharma Group Ltd (MAYNF) (H1 2025) Earnings Call Highlights: Strong Growth in Women's ...

Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology

Discover ASX Penny Stocks Featuring Mayne Pharma Group And Two Others

Discover 3 ASX Penny Stocks With Market Caps Over A$100M

Discover Alto Metals And 2 More Exciting Penny Stocks On The ASX

FEDERAL CONTRACEPTION PROPOSAL TO EXPAND ACCESS AND AFFORDABLE COVERAGE PAVES A STRONGER PATH FOR MAYNE PHARMA'S GROWTH IN WOMEN'S HEALTH

Discover 3 ASX Penny Stocks With Market Caps Over A$200M

Several Insiders Invested In Mayne Pharma Group Flagging Positive News

Shareholders in Mayne Pharma Group (ASX:MYX) are in the red if they invested five years ago

Mayne Pharma Group Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Australia's Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement

ASX Growth Companies With Insider Ownership As High As 35%

Mayne Pharma Group Limited's (ASX:MYX) largest shareholders are individual investors with 38% ownership, institutions own 33%

Favourable Signals For Mayne Pharma Group: Numerous Insiders Acquired Stock

Performance Overview